Germany and Israel
Coramaze
medical device
active
Coramaze Technologies focuses on developing new technologies to address unmet needs in the treatment of heart valve disease. The company’s Mitramaze® valve repair system is designed for the treatment of severe functional mitral regurgitation (fMR) through transfemoral implantation into a beating heart. Until recently, many patients with severe fMR were excluded from standard surgical mitral valve treatment options due to their advanced age or comorbidities.
visit Coramaze's website
www.coramaze.com
contact
You would like to invest into the next big thing?
As a long-term investor with a track record of creating successful and sustainable businesses, our goal is to deliver attractive strategic and financial returns to our investors.
